Slide 1: Fiscal Year Ended September 30, 2012 Investor Presentation
Fiscal Year Ended September 30, 2012 Investor Presentation
Slide 2: Important Notice
Important Notice This presentation contains “forward looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to risks and uncertainties. Actual outcomes and results could differ materially from those suggested by this presentation du
Slide 3: Financial & Portfolio Highlights
Financial & Portfolio Highlights Financial Highlights Q4-12 Q3-12 Q2-12 Q1-12 Q4-11 Q3-11 Q2-11 Net investment income per share $ 0.36 $ 0.36 $ 0.31 $ 0.28 $ 0.26 $ 0.21 $ 0.10 Net realized g gains ((losses)) ((0.01)) - - - - - - Net unrealized gains (losses) 0.02 (0.08) 0.03 (0.03) (0.03) 0.02 - Ne
Slide 4: Select Financial & Portfolio Information
Select Financial & Portfolio Information As of and for the Three Months Ended (dollars in millions, except per share data) 9/30/2012 6/30/2012 3/31/2012 12/31/2011 9/30/2011 6/30/2011 3/31/2011 Net investment income per share - basic & diluted $ 0.36 $ 0.36 $ 0.31 $ 0.28 $ 0.26 $ 0.21 $ 0.10 Net rea
Slide 5: Balance Sheet
Balance Sheet 9/30/2012 6/30/2012 3/31/2012 12/31/2011 9/30/2011 6/30/2011 3/31/2011 ASSETS (Audited) (Unaudited) (Unaudited) (Unaudited) (Audited) (Unaudited) (Unaudited) Investments at fair value Non-control/non-affiliate investments $ 393,741,357 $ 355,035,060 $ 260,364,140 $ 198,238,921 $ 153,38
Slide 6: Portfolio Summary as of September 30, 2012
Portfolio Summary as of September30, 2012 1 Portfolio by Issuer Water Capital USA, Inc. Calloway Laboratories, Inc. 1% 1% 1% 1%0% 6% 1%1% RCS Management Corporation & Specialized Medical Services, Inc Modern VideoFilm, Inc. 2% 5% 2% Strike Holdings LLC Aurora Flight Sciences Corporation 2% 2% 5% Rev
Slide 7: Performance Overview
Performance Overview Consistent quarterly dividend ($0.36 for quarter ending 9/30/12) Diversified portfolio with no assets on non non-accrual accrual and a weighted average loan loan-to-value to value (through MCC’s debt) of 52.3% 14.3% portfolio yield as of 9/30/121 FY Q4 2012 gross investm
Slide 8: Performance Since IPO
Performance Since IPO Dividend Growth Portfolio Growth $0.40 $450.0 $400.0 $0.35 $350 0 $350.0 $0.30 $300.0 ($ millions) $0.25 $250.0 $0.20 $0.36 $0.36 $200.0 402 363 $0.15 $0.31 $0.28 $150.0 306 $0.25 249 $0.10 $0.21 $100 0 $100.0 199 $0.16 145 $0.05 $50.0 105 85 $0.00 $0.0 3/31/11 6/30/11 9/30/11
Slide 9: Transaction & Backlog Summary
Transaction & Backlog Summary 1 2 Deal Sector Security $Amount Fixed/Floating Tenor Yield Closed in Q1 FY12 Renaissance Learning, LLC Healthcare, Education and Childcare Senior - 1st/2nd lien $4.8 Floating 6.4 years 10.9% Hoffmaster Group, Inc. Personal & Nondurable Consumer Products Senior - 1st/2n
Slide 10: Corporate Information
Corporate Information Board of Directors Corporate Officers Research Coverage Corporate Counsel BROOK TAUBE BROOK TAUBE UBS INVESTMENT RESEARCH SUTHERLAND ASBIL & Chairman & Chief Executive Officer Chairman & Chief Executive Officer Abu Ramin – (212)-713-1422 BRENNAN LLP Washington, DC ANDREW FENTRE